Literature DB >> 15247047

Alternative pathways might mediate toxicity of high concentrations of superoxide dismutase.

Axel Kowald1, Edda Klipp.   

Abstract

One of the most important antioxidant enzymes is superoxide dismutase (SOD), which catalyzes the dismutation of superoxide radicals to peroxide. The gene for CuZnSOD lies in humans on chromosome 21, and its activity is increased in patients with Down syndrome. However, instead of being beneficial, increased lipid peroxidation is associated with this increased expression, and also studies on bacteria and transgenic animals show that high levels of SOD actually lead to increased lipid peroxidation and hypersensitivity to oxidative stress. Using mathematical models, we investigated the question of how overexpression of SOD can lead to increased oxidative stress, although it is an antioxidant enzyme. We considered several possibilities that have been proposed in the literature, such as CuZnSOD-catalyzed hydroxyl radical formation, superoxide-mediated inhibition of membrane peroxidation, and short-circuiting of the Cu(I)ZnSOD/Cu(II)ZnSOD redox cycle. We found that one of the proposed mechanisms under certain circumstances is able to explain the increased oxidative stress caused by SOD. Furthermore, we identified an additional mechanism that agrees well with experimental observations. We call it the "alternative pathway" mechanism, because it depends on superoxide radicals having alternative pathways besides their reaction with SOD. The alternative pathway mechanism is a very general explanation for SOD-associated oxidative stress, because it does not depend on the specific type of SOD, nor on the redox status of the cell. We therefore think that it might be the common mechanism for the detrimental effects seen in cells and organisms with increased levels of the different forms of superoxide dismutase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247047     DOI: 10.1196/annals.1297.065

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  Linking mitochondrial bioenergetics to insulin resistance via redox biology.

Authors:  Kelsey H Fisher-Wellman; P Darrell Neufer
Journal:  Trends Endocrinol Metab       Date:  2012-02-02       Impact factor: 12.015

2.  SOD2 overexpression: enhanced mitochondrial tolerance but absence of effect on UCP activity.

Authors:  José P Silva; Irina G Shabalina; Eric Dufour; Natasa Petrovic; Emma C Backlund; Kjell Hultenby; Rolf Wibom; Jan Nedergaard; Barbara Cannon; Nils-Göran Larsson
Journal:  EMBO J       Date:  2005-11-10       Impact factor: 11.598

Review 3.  Mathematical and computational models of oxidative and nitrosative stress.

Authors:  Mahendra Kavdia
Journal:  Crit Rev Biomed Eng       Date:  2011

4.  Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.

Authors:  Maureen M O'Brien; Jeffrey W Taub; Myron N Chang; Gita V Massey; Kimo C Stine; Susana C Raimondi; David Becton; Yaddanapudi Ravindranath; Gary V Dahl
Journal:  J Clin Oncol       Date:  2008-01-20       Impact factor: 44.544

5.  Integrative Model of Oxidative Stress Adaptation in the Fungal Pathogen Candida albicans.

Authors:  Chandrasekaran Komalapriya; Despoina Kaloriti; Anna T Tillmann; Zhikang Yin; Carmen Herrero-de-Dios; Mette D Jacobsen; Rodrigo C Belmonte; Gary Cameron; Ken Haynes; Celso Grebogi; Alessandro P S de Moura; Neil A R Gow; Marco Thiel; Janet Quinn; Alistair J P Brown; M Carmen Romano
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

6.  Dual Regulation of Cell Death and Cell Survival upon Induction of Cellular Stress by Isopimara-7,15-Dien-19-Oic Acid in Cervical Cancer, HeLa Cells In vitro.

Authors:  Nadiah Abu; Swee K Yeap; Ahmad Z Mat Pauzi; M Nadeem Akhtar; Nur R Zamberi; Jamil Ismail; Seema Zareen; Noorjahan B Alitheen
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.